Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 96/100

Q2 2020 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Oct 23, 2019 / 12:30PM GMT
Release Date Price: ₹840.13 (+0.61%)
Operator

Ladies and gentlemen, good day, and welcome to the Torrent Pharmaceuticals Limited Q2 FY '20 Earnings Conference Call. We have with us on the call today Mr. Sanjay Gupta, Executive Director, International business; Mr. Sudhir Menon, Chief Financial Officer; and Mr. Aman Mehta, Chief Marketing Officer, India Business.

(Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sanjay Gupta. Thank you and over to you, sir.

Sanjay Gupta
Torrent Pharmaceuticals Limited - Executive Director of International Business

Thank you, Raymond. Good evening, everyone, and welcome to our Q2 FY '20 earnings call. Let's start with the financial results. Q2 revenues were INR 2,005 crores, up by 6% on a year-on-year basis. EBITDA was INR 573 crores, up by 20% on a year-on-year basis, and EBITDA margins were at 28.6%, an improvement of 1% on a Q-on-Q basis and 3.3% on a year-on-year basis.

I would now like to take you through some trends in our key markets. India contributed 45% of our total

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot